BioSpace News Archive

Biotech Bay

Pulse Biosciences Quarterly Investor Conference Call for the Quarter Ended September 30, 2017

Cash and investments totaled $42.0 million at September 30, 2017, compared to $16.4 million at December 31, 2016, reflects the proceeds from the $30 million financing completed in September.

November 7, 2017
·
8 min read
Business

InspireMD Announces Third Quarter 2017 Results; CGuard Revenue Increases 90% Versus Same Period Last Year

Revenue for the third quarter ended September 30, 2017 was $718,000 compared to $469,000 during the same period in 2016.

November 7, 2017
·
18 min read
Business

Cutera Reports Third Quarter 2017 Financial Results

Revenue increased 26%, to a record $38.2 million, primarily due to 57% growth in North America Systems revenue.

November 7, 2017
·
28 min read
Business

Invuity Reports 2017 Third Quarter Financial Results

Revenue was $9.6 million in the third quarter of 2017, up 13% from revenue of $8.5 million in the third quarter of 2016 driven by an increase in active accounts. Management estimates that approximately $400,000 in revenue was lost due to the impact of hurricanes.

November 7, 2017
·
10 min read
Business

Retrophin Reports Third Quarter 2017 Financial Results

Net product sales for the third quarter of 2017 were $40.3 million, compared to $33.9 million for the same period in 2016.

November 7, 2017
·
25 min read
Genetown

Sarepta Therapeutics Announces Proposed Offering of $375 Million of Convertible Senior Notes Due 2024

The notes will be offered and sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

November 7, 2017
·
6 min read
Business

Electromed Announces Fiscal 2018 First Quarter Financial Results

Gross profit rose 14.1% to $4.9 million from $4.3 million in Q1 FY 2017.

November 7, 2017
·
9 min read
Business

Invacare Reports Results for Third Quarter 2017

Reported net sales decreased 6.4% to $250.9 million compared to the third quarter last year.

November 7, 2017
·
24 min read
Business

Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results

Navidea reported total revenues for the quarter of $224,000.

November 7, 2017
·
12 min read
Business

Effective Immediately: OncoSec Names Former Advaxis Exec as New CEO

OncoSec Medical today announced the appointment of Daniel J. O’Connor as CEO of the Company.

November 7, 2017
·
6 min read